Bebbington, Christopher Robert,Youngblood, Bradford Andrew,Tomasevic, Nenad
申请号：
AU2018261887
公开号：
AU2018261887A1
申请日:
2018.05.04
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The present disclosure provides methods for the treatment of an allergic ocular disease (e.g., allergic conjunctivitis, keratoconjunctivitis, or giant papillary conjunctivitis). In particular, the present disclosure provides methods for the treatment of an allergic ocular disease through administration of antibodies that bind to human Siglec-8 or compositions comprising said antibodies. The present disclosure also provides articles of manufacture or kits comprising antibodies that bind to human Siglec-8 for the treatment of an allergic ocular disease.
